Without heavy investment in research and development (R&D), the millions of new and innovative medical technologies, drugs and delivery systems developed each year would simply not happen. In 2018, the UK’s medical funding body – the Medical Research Council – recorded a gross expenditure of £814 million. This figure...
In this expert interview, Debbie Barklamb, Account Manager with IDBS, explains how she works with our customers, coordinating resources to help them successfully onboard IDBS software. This includes helping new customers adopt and roll out our software and ensuring that existing customers continue to benefit from the technology and...
In the past, searching for experiment data has been a challenge in the R&D space. Science laboratories can have hundreds of employees and perform an enormous number of experiments each year. While a lab notebook is indispensable to scientific study, the paper-based notebook definitely has its limits. Electronic data...
A record number of visitors attended this year event, that ran from 2nd-5th April in Vienna. Those who attended were not only treated to the beautiful city views but also the most exciting and recent innovations advances in the biologics development space, including technological advances in bioprocessing, highlights of...
Are you involved in, or researching, novel bioanalytical solutions and innovations in drug discovery and development? Then WRIB is the place to be this April. Built on the success of the previous annual meetings, the 13th WRIB offers discussions on trending topics in bioanalysis, biomarkers and immunogenicity and we...
Looking to explore the latest advancements in scientific processes and technology across the bioprocessing world? BioProcess International Europe this April has it all and much, much more. At IDBS, we’re delighted to sponsor, speak and participate at this conference, at booth #93, which boasts more than 900 decision-makers and...
The date when the UK should be leaving the EU, colloquially known as ‘Brexit’, is approaching fast. Despite the nature of this event, there is still a great deal of uncertainty around how it will happen, when and if indeed it will happen at all… Add to this that...
In bioanalysis firms, there’s a lot of pressure to do more with less. This means there’s a huge focus on increasing throughput in the laboratory, and contracting the QC timeline – either by the training of scientists or the use of software – whilst complying with legal regulations and...
In 2001, the FDA published the first version of the Bioanalytical Method Validation (BMV) Guidance for the bioanalysis industry. Over the next 17 years, the FDA would come out with another draft document, followed by a final version in 2018, based on scientist’s laboratory suggestions. Scientists were encouraged to...
Do you want to increase efficiency, enhance connectivity and drive superior quality in your lab? Then you need to attend this year’s SmartLab Digital event. SmartLab Digital is an online series of live interactive webinars with hand-picked case studies by pharmaceutical industry experts and thought leaders all focused on...
